In post-menopausal women, there was a weaker positive association between IGF-1 and breast cancer risk (HR per 5 nmol/L increment: 1.07; 95% CI: 1.01, 1.12) (Table 2 and Supplementary Fig. S2). This evidence concerns the gene IGF1 and breast cancer.